AVANIR Stock to Commence Trading on the NASDAQ National Market System
11 Aprile 2006 - 2:00PM
Business Wire
AVANIR Pharmaceuticals (NASDAQ:AVNR) announced that at market open
today, the Company's stock will resume trading on the NASDAQ(R)
National Market System under the new ticker symbol "AVNR" and
discontinue trading on the American Stock Exchange (AMEX) under its
previous ticker symbol "AVN.R." "We want to thank the AMEX for
their strong support and professionalism over the last six years,"
said Eric K. Brandt, President and Chief Executive Officer of
AVANIR. "Today's action provides our shareholders with the
additional benefits that come with listing on NASDAQ. This change,
along with the recent news of the FDA's acceptance for filing and
priority review designation of our Neurodex new drug application,
continues to make 2006 a very exciting year for our Company." About
AVANIR AVANIR Pharmaceuticals is focused on developing and
commercializing novel therapeutic products for the treatment of
chronic diseases. AVANIR's product candidates address therapeutic
markets that include central nervous system and cardiovascular
disorders, inflammation, and infectious diseases. AVANIR previously
announced positive results in the second of two required Phase III
clinical trials of Neurodex(TM), an investigational new drug for
the treatment of involuntary emotional expression disorder (IEED).
Additionally, AVANIR has initiated a Phase III clinical trial for
Neurodex as a potential treatment in patients with diabetic
neuropathic pain, a second indication for Neurodex. AVANIR has
active collaborations with two international pharmaceutical
companies: Novartis International Pharmaceutical Ltd., for the
treatment of inflammatory disease, and AstraZeneca, for the
treatment of cardiovascular disease. The Company's first
commercialized product, "abreva(R)," is marketed in North America
by GlaxoSmithKline Consumer Healthcare and is the leading
over-the-counter product for the treatment of cold sores. Further
information about AVANIR can be found at www.avanir.com.
Grafico Azioni Avanir (AMEX:AVN.R)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Avanir (AMEX:AVN.R)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Avanir Pharmaceuticl (Borsa Americana (AMEX)): 0 articoli recenti
Più AVANIR Pharmaceuticals Articoli Notizie